申请人:Sankyo Company, Limited
公开号:US04992451A1
公开(公告)日:1991-02-12
1,4-Dihydro-6-methyl-4-(substituted phenyl)pyridine-3,5-dicarboxylic acid esters have an amino group at the 2-position and at least one nitrooxy group in at least one of the ester groups. These compounds have a variety of valuable activities, including antihypertensive and Ca.sup.++ -blocking activities, leading to their use for the treatment of circulatory and coronary disorders. They may be prepared by condensation of appropriate substituted acetic acid esters.
1,4-二氢-6-甲基-4-(取代苯基)吡啶-3,5-二羧酸酯在2位上具有氨基,至少一个酯基中至少有一个亚硝氧基。这些化合物具有多种有价值的活性,包括降压和钙离子阻滞活性,因此可用于治疗循环和冠心病等疾病。它们可以通过适当的取代乙酸酯的缩合反应制备。